BioSpace News Archive

Rapid Dose Therapeutics Corp. announced that they have completed the last phase of the Managed Strip Services Agreement signed in January 2019 with Flower One Holdings Inc., pursuant to which Flower One has been granted Gold Vendor Status to manufacture, distribute and sell RDT’s QuickStrip™, an innovative, proprietary delivery technology, for the cannabis market in Nevada, USA.

ADVANZ PHARMA Corp. commented on the issuance by the UK Competition and Markets Authority of a Statement of Objections to various parties, including ADVANZ PHARMA, related to competition matters pertaining to the Company’s medicines, nitrofurantoin capsules 50mg and 100mg.

Concert Pharmaceuticals, Inc. announced that it will report its second quarter 2019 financial results on Thursday, August 1, 2019, before the U.S. financial markets open.

Bristol-Myers Squibb Company (NYSE:BMY) reported results for the second quarter of 2019, which were highlighted by strong sales for Eliquis (apixaban) and Opdivo (nivolumab) and a robust operating performance across the portfolio.

LabCorp® announced results for the second quarter ended June 30, 2019, and updated 2019 guidance.

NDA Seeks Approval for Brinavess for the Treatment of Recent Onset Atrial Fibrillation; PDUFA Date Set for December 24, 2019

Executive Management to Host Conference Call on August 6, 2019 at 4:30 p.m. ET

Verastem, Inc. announced that the Company will host a conference call and webcast on Thursday, August 1, 2019 at 4:30 p.m. Eastern Time to discuss corporate updates and financial results for the second quarter ended June 30, 2019.

22 delegates from Higher Education Institutions of Israel visited South Korea’s Konkuk University on July 17 and discussed research cooperation and academic exchange between Israeli universities and Konkuk University.

Covalon Technologies Ltd., an advanced medical technologies company, wishes to provide the following corporate update